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Abstract
Background: Mycobacteria produce two unique families of cytoplasmic polymethylated polysaccharides - the
methylglucose lipopolysaccharides (MGLPs) and the methylmannose polysaccharides (MMPs) - the physiological functions
of which are still poorly defined. Towards defining the roles of these polysaccharides in mycobacterial physiology, we
generated knock-out mutations of genes in their putative biosynthetic pathways.
Methodology/Principal Findings: We report here on the characterization of the Rv1208 protein of Mycobacterium
tuberculosis and its ortholog in Mycobacterium smegmatis (MSMEG_5084) as the enzymes responsible for the transfer of the
first glucose residue of MGLPs. Disruption of MSMEG_5084 in M. smegmatis resulted in a dramatic decrease in MGLP
synthesis directly attributable to the almost complete abolition of glucosyl-3-phosphoglycerate synthase activity in this
strain. Synthesis of MGLPs in the mutant was restored upon complementation with wild-type copies of the Rv1208 gene
from M. tuberculosis or MSMEG_5084 from M. smegmatis.
Conclusions/Significance: This is the first evidence linking Rv1208 to MGLP biosynthesis. Thus, the first step in the initiation
of MGLP biosynthesis in mycobacteria has been defined, and subsequent steps can be inferred.
Citation: Kaur D, Pham H, Larrouy-Maumus G, Rivie `re M, Vissa V, et al. (2009) Initiation of Methylglucose Lipopolysaccharide Biosynthesis in Mycobacteria. PLoS
ONE 4(5): e5447. doi:10.1371/journal.pone.0005447
Editor: Christophe Herman, Baylor College of Medicine, United States of America
Received February 11, 2009; Accepted April 10, 2009; Published May 7, 2009
Copyright:  2009 Kaur et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by the National Institute of Allergy and Infectious Diseases/National Institutes of Health grant R01AI064798. The funder had
no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: Mary.Jackson@colostate.edu
Introduction
Mycobacteria produce two cytoplasmic polymethylated poly-
saccharides (PMPS) of intermediate size in which many of the
sugar units are partially O-methylated, thus conferring on the
molecules a slight hydrophobicity [1]. One class is known as the 3-
O-methylmannose polysaccharides (MMPs) [2–3] and the other as
the 6-O-methylglucose lipopolysaccharides (MGLPs) (Fig. 1) [4–5].
The ability of both PMPS to form in vitro stable complexes with
medium- and long-chain fatty acyl chains and acyl-CoAs and to
regulate the activity of the fatty acid synthase I (FAS-I) has led to
the hypothesis that these polysaccharides are important regulators
of fatty acid and mycolic acid metabolism in mycobacteria [6–8].
These findings, however, have been derived from in vitro studies
using enzyme assays and purified substrates and whether they
accurately reflect the physiological function of PMPS in whole cells
is not clear. With the ultimate goal of studying the physiological
roles of MMPs and MGLPs, we have begun to define their
biosynthetic pathways and to generate mycobacterial mutants
deficient in different aspects of their biosynthesis [1,9].
Our recent evidence indicates that two clusters of genes are
likely to participate in the biosynthesis of MGLPs in M. tuberculosis.
One encompasses Rv3030-Rv3037c in the genome of M. tuberculosis
H37Rv [10] and carries the a-(1R4)-glucosyltransferase gene
(Rv3032) responsible for the elongation of MGLPs [9], a putative
acetyltransferase gene (Rv3034c), two putative SAM-dependent-
methyltransferase genes (Rv3030 and Rv3037c) and a potential
branching gene (Rv3031) likely to be involved in the formation of
the a-(1R6)-glycosidic bond linking the first and second D-Glcp
residues at the reducing end of the molecule. The finding that a M.
tuberculosis H37Rv knock-out mutant deficient in the Rv3032
enzyme still produced residual amounts of MGLPs then led us to
identify Rv1212c as the likely compensatory a-(1R4)-glucosyl-
transferase [11]. Failure to disrupt both the Rv3032 and Rv1212c
genes in the same M. tuberculosis H37Rv strain further indicated
that bacterial growth required at least one of these two genes to be
functional. Whether this physiological requirement is particularly
related to the synthesis of glycogen, capsular glucan or MGLPs has
not yet been elucidated, since Rv3032 and Rv1212c appear to
participate in the elongation of all three molecules and to partially
compensate for one another [11]. Interestingly, Rv1212c also
belongs to a cluster of genes (Rv1208–Rv1213) encoding putative
sugar-modifying enzymes [1,11]. The existence of a putative
retaining glycosyltransferase of the recently established CAZy GT-
81 family (http://www.cazy.org/), Rv1208, showing weak se-
quence similarities with the glucosyl-3-phosphoglycerate synthase
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vicinity of Rv1212c suggested that Rv1208 might catalyze the first
glucosyl transfer in MGLP biosynthesis (Fig. 1) [12]. Supporting
this assumption, recombinant forms of the orthologs of Rv1208
from Mycobacterium bovis BCG and M. smegmatis have been shown to
display GpgS activity in vitro [13]. Moreover, the three-dimen-
sional structures of Rv1208 and its ortholog in M. avium subsp.
paratuberculosis, MAP2569c, in their apo forms and in complex with
UDP, UDP-glucose, and both UDP and D-3-phosphoglycerate
have been solved allowing the classification of these enzymes as
GT-A-type glycosyltransferases and the molecular determinants
for substrate recognition and catalysis to be established [14–15].
Direct evidence linking this enzyme to the biogenesis of MGLPs in
mycobacteria was, however, lacking. Rv1208 was predicted to be
Figure 1. Structure and early biosynthetic steps of MGLPs. The catalytic steps leading to the synthesis of glucosylglycerate and genes
thought to be involved in the elongation of MGLPs are represented. MGLPs from M. bovis BCG are composed of 10 a2(1R4)-linked 6-O-
methylglucosyl residues with a non-reducing end made of the tetrasaccharide 3-O-methyl-D-Glcp-[a(1R4)-D-Glcp]3-a(1R. The tetrasaccharide R4)-
[a2(1R4)-D-Glcp]3-a2(1R6)-D-Glcp-a2(1Rlinked to the position 2 of D-glyceric acid constitutes the reducing end of the molecule. The second and
fourth a-D-Glcp residues (closest to the reducing end) are substituted at position 3 by single b-D-Glcp residues. The non-reducing end of the polymer
is acylated by a combination of acetate, propionate and isobutyrate (R9), whereas octanoate (R) esterifies the position 1 of glyceric acid and zero to
three succinate groups (R0) esterify the Glc residues of the reducing end. MGLPs occur as a mixture of four main components that differ in their
content of esterified succinic acid.
doi:10.1371/journal.pone.0005447.g001
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[16]. We thus undertook to analyze the effects of disrupting
MSMEG_5084, the ortholog of Rv1208 in M. smegmatis, on the
GpgS activity and MGLP synthesis of this bacterium. An assay
was developed which allowed the formation of the early precursors
of MGLPs to be monitored in mycobacterial cell-free extracts for
the first time.
Results and Discussion
Effects of knocking-out MSMEG_5084 on the
biosynthesis of MGLP in M. smegmatis
The ortholog of the Rv1208 gene in M. smegmatis mc
2155,
MSMEG_5084, was disrupted by homologous recombination
using standard protocols [17]. The product of MSMEG_5084
(303 amino acids) shares 74% identity (84% similarity) with its M.
tuberculosis counterpart (324 amino acids) on a 302 amino acid
overlap. Allelic replacement at the MSMEG_5084 locus was
confirmed by PCR and Southern hybridization (Fig. 2 and data
not shown). Complemented mutant strains were obtained by
transforming mc
2DMSMEG_5084 either with pVV2Rv1208,
expressing a wild-type copy of Rv1208 from M. tuberculosis
H37Rv or pVV16MSMEG_5084, expressing a wild-type copy of
MSMEG_5084 from M. smegmatis mc
2155.
As compared to its wild-type parent M. smegmatis mc
2155, the
MSMEG_5084 mutant displayed a significantly reduced growth
rate at 37uC. Mutant colonies typically appeared 3 to 4 days later
than wild-type colonies on 7H11-OADC, and 1 to 2 days later
than mc
2155/pVV16MSMEG_5084 colonies. Thus, growth was
partially restored in the complemented mutants.
Analysis of the MGLPs produced by different culture batches of
the wild-type and mutant strains metabolically labeled with [
14C-
methyl]-L-methionine [9] revealed a virtual elimination of the de
novo production of these molecules in the mutant (Fig. 3). MGLP
production was restored in the mutant complemented with wild-
type copies of either Rv1208 or MSMEG_5084 indicating that the
two genes are functional orthologs (Fig. 3). The total amount of
radioactivity incorporated into the MGLPs of the mutant was only
about 20% of that for the wild-type parent. MMP synthesis, in
contrast, appeared relatively unaffected in mc
2DMSMEG_5084
indicating that a deficiency in MGLP production does not affect
other PMPS (Fig. 3). These results clearly confirm the primary role
of Rv1208 in the initiation of MGLP synthesis, however, since
residual amounts of MGLPs were still produced in the mutant, we
conclude that another enzyme displaying glucosyl-3-phosphoglyc-
erate synthase or glucosylglycerate synthase activity contributed to
the pool.
To compare the structures of the MGLPs produced by the wild-
type, mutant and complemented mutant strains, they were
purified by reverse phase chromatography, deacylated, peracety-
lated and analyzed by MALDI-TOF mass spectrometry. The mass
spectrum of the MGP fraction of wild-type M. smegmatis mc
2155
mainly showed four series of ions separated by 260 mass units and
differing by 28 and 16 mass units attributable to the peracetylation
of the samples (i.e., replacement of a methyl group by an acetyl
group) and potassium adducts of the pseudomolecular ions,
respectively (Fig. 4). The observed clustered ions thus reflect the
variability of MGPs in terms of their degree of glycosylation, O-
methylation and salt (sodium, potassium) adducts. In the wild-type
strain, the two most intense ions at m/z 5253 and 5513 were
assigned, respectively, to the [M-H+2Na]
+ pseudomolecular ions
of MGP19,12 and MGP20,12 (MGP containing 19 and 20 glucose
units, among which 12 are O-methylated) (Fig. 4). In contrast,
mc
2DMSMEG_5084 accumulated lower molecular weight MGP
species, consisting of 17 and 18 Glc residues (MGP17,12, MGP17,13,
MGP18,12, MGP18,13); although MGP19,12, MGP19,13, MGP20,12,
MGP20,13 were detectable in the mutant strain, the abundance of
these was clearly much less than in the wild-type strain (Fig. 4).
Thus, disrupting MSMEG_5084 in M. smegmatis resulted primarily
in simple, less polymerized structures, and also diminished yields.
Complementation of the mutant strain with pVV16MSMEG_5084
partially restored the synthesis of the mature forms of MGPs
(MGP19,12, MGP20,12) in the cells (Fig. 4).
No qualitative or quantitative differences were found between
the mutant and wild-type strains in terms of fatty acid and mycolic
acid contents (Fig. S1). Thus, altered biosynthetic patterns of
MGLPs had no significant impact on fatty acid metabolism. This
result is consistent with observations reported by Dr. Ballou’s
laboratory on a spontaneous mutant of M. smegmatis with defects in
MMP and MGLP synthesis [18] and our own observations on a
Rv3032 knock-out mutant of M. tuberculosis H37Rv and a
MSMEG_2350 knock-out mutant of M. smegmatis mc
2155, both
of which were found to be significantly impaired in MGLP
biosynthesis but not in that of fatty acids and mycolates [9].
Although the presence of MMPs (which are thought to play similar
regulatory functions as MGLPs on fatty acid synthesis) in
Figure 2. Generation of a MSMEG_5084 knock-out mutant of M.
smegmatis. Evidence for allelic replacement at the MSMEG_5084 locus
of M. smegmatis. Allelic replacement was confirmed by PCR using
primers smeg1208.3 and smeg1208.4 (see Materials and Methods). The
WT 2,422-bp amplification signal is replaced by a 3,622-bp fragment in
the mutant due to the insertion of a 1.2 kb- kanamycin resistance
cassette.
doi:10.1371/journal.pone.0005447.g002
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2DMSMEG_5084 might account at least in part for this result,
this study casts further doubts on the prevailing hypothesis that
MGLPs are, in vivo, involved in the regulation of fatty acid
synthesis [1].
Effects of knocking-out MSMEG_5084 on the
biosynthesis of MGLP precursors by M. smegmatis cell-
free extracts
To directly correlate Rv1208 and glucosyl-3-phosphoglycerate
synthase activity to the biosynthesis of MGLPs in mycobacterial
cells, whole cell lysates prepared from the wild-type and mutant
strains of M. smegmatis provided enzyme sources in assays aimed at
monitoring the formation of glucosylglycerate and MGLP
precursors in vitro. UDP-D-[U-
14C]Glc and D-3-phosphoglycerate
served as the donor and acceptor substrates, respectively. Time-
dependent formation of glucosyl-3-phosphoglycerate (GPG) was
clearly visible in the cell-free extracts of wild-type M. smegmatis
(Fig. 5). As expected, this product was progressively dephosphor-
ylated by an unknown endogenous phosphatase, GlgP (Fig. 1), to
yield glucosylglycerate (GG) (Fig. 5). In contrast, barely detectable
amounts of GPG and no GG were detected in the assays using
mc
2DMSMEG_5084 extracts (Fig. 5), even after prolonged
incubation times.
In conclusion, the disruption of MSMEG_5084 in M. smegmatis
results in an 80% decrease in the production of MGLPs directly
attributable to a drastic if not complete loss of GPG synthesis. The
dispensability of the MSMEG_5084 gene for the growth of M.
smegmatis while its ortholog in M. tuberculosis H37Rv, Rv1208,i s
predicted to be essential may be accounted for by the existence of
residual amounts of MGLPs in mc
2DMSMEG_5084 or by the
production by M. smegmatis mc
2155 but not M. tuberculosis H37Rv
of MMPs thought to display the same physiological functions as
MGLPs [1]. Altogether, our results indicate that Rv1208 and its
ortholog in M. smegmatis encode glucosyl-3-phosphoglycerate
synthases involved in the transfer of the first glucosyl residue of
MGLPs. Results also confirm the participation of two gene clusters
in the biosynthesis of these lipopolysaccharides in the genomes of
mycobacteria. The existence of endogenous enzymes with weak
glucosyl-3-phosphoglycerate synthase or glucosylglycerate syn-
thase activity probably account for the residual synthesis of
MGLPs in the MSMEG_5084 mutant of M. smegmatis.
Materials and Methods
Construction of a M. smegmatis MSMEG_5084 knock-out
mutant
A two-step homologous recombination procedure using the
counterselectable marker sacB [17] was used to achieve allelic
replacement at the MSMEG_5084 locus of M. smegmatis mc
2155.
The MSMEG_5084 gene and flanking regions were PCR-
amplified from M. smegmatis mc
2155 genomic DNA using the
forward (smeg1208.1) 59-tataagaattcctacggcatcagcgagcg-39 and
reverse (smeg1208.2) 59-tataagcggccgcgcggttgcgcacgatcc-39 prim-
ers and a disrupted allele, MSMEG_5084::km, was obtained by
inserting the kanamycin resistance cassette from pUC4K (Amer-
sham Pharmacia Biotech) into the PstI restriction site of
MSMEG_5084. MSMEG_5084::km was then cloned into the
NotI-cut and blunt-ended pJQ200-xylE [17] to obtain pJQ200-
xylE- MSMEG_5084::km, the construct used for allelic replace-
ment. Allelic replacement at the MSMEG_5084 locus was
confirmed by PCR using primers smeg1208.3 (59-atcgagtggctgcg-
cagc-39) and smeg1208.4 (59-gcacttgcgacatgtcgg-39) and Southern
blot as described [19].
For complementation studies, the entire coding sequence of
Rv1208 was PCR-amplified from M. tuberculosis H37Rv genomic
DNA using the primers 59-tataacatatgacagcatcggagctggtc-39 and
59-tataaaagcttcagcgcggccgcatcac-39 and cloned into the NdeI and
HindIII restriction sites of the expression vector pVV2, yielding
pVV2Rv1208. pVV2 is a shuttle E. coli/Mycobacterium plasmid
derived from pMV261 [20]. It harbors kanamycin and hygro-
mycin-resistance markers and allows the constitutive production of
N-terminal His6-tagged proteins in mycobacteria under the
control of the phsp60 promoter. MSMEG_5084 was PCR-
Figure 3. MGLP synthesis by M. smegmatis wild-type and MSMEG_5084 mutant. TLC autoradiograph of the [
14C-methyl]-L-methionine-
labeled and partially purified MGLPs from mc
2155 wild-type (WT), mc
2DMSMEG_5084,m c
2DMSMEG_5084/pVV2Rv1208 and mc
2DMSMEG_5084/
pVV16MSMEG_5084. PMPS were extracted from bacterial cells and purified by reverse phase chromatography on SepPakH Plus tC18 columns
(Waters); 1: fraction eluted with 20% methanol; 2: fraction eluted with 40% methanol; 3: fraction eluted with 70% methanol. MGLPs were prepared
from the same amounts of wild-type, mutant and complemented mutant cells.
doi:10.1371/journal.pone.0005447.g003
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above and cloned into the blunted SpeI site of pVV16 [19] for
expression from its own promoter.
Whole cell radiolabeling experiments
Radiolabeling with [
14C-methyl]-L-methionine (0.5 mCi ml
21;
specific activity, 55 Ci mol
21, Amersham) was performed at 37uC
in Sauton’s medium for 24 hr as described [9].
Purification and analysis of MGLPs
MGLPs were extracted and purified from cold and radiolabeled
M. smegmatis Sauton’s cultures as previously described [9]. TLC
analyses were performed on aluminum-backed silica gel 60-
precoated plates F254 (E. Merck, Darmstadt, Germany) using
chloroform/methanol/water (56:38:10, by vol.) as the eluent.
Radiolabeled MGLPs were visualized by exposure of TLC plates
to Kodak X-Omat AR films at 280uC. MGPs were obtained by
deacylating dry MGLPs in 1 M NaOH at 37uC for 3 hr as
described [9]. Samples (5–10 mg) were peracetylated with 100 ml
acetic anhydride in the presence of 100 ml of pyridine for 1 hr at
110uC. After removal of the solvent, peracetylated MGPs were
extracted three times with chloroform/water (1:1). The chloro-
form phases were pooled, washed three times with water, and the
dried residue dissolved in 10 ml chloroform prior to Matrix-
Assisted Laser Desorption-Ionization Time-Of-Flight (MALDI-
TOF) Mass Spectrometry (MS). Typically, 0.5 ml of the
peracetylated MGP sample in chloroform was mixed with
0.5 ml of matrix solution (dihydroxybenzoic acid 10 mg/ml in
50% ethanol) directly on the MALDI target plate. MALDI-TOF
MS analyses were performed on a MALDI-TOF Voyager DE
STR (Applied Biosystems, Framinham, MA) calibrated using the
instrument’s external calibration procedure, in positive ion
reflector mode using 20 kV accelerating voltage with an
extraction delay of 200 nsec.
Figure 4. MGP composition of the wild-type, MSMEG_5084 mutant and complemented mutant strains of M. smegmatis. Partial high
mass range (m/z 4500–6000) MALDI-TOF mass spectra in the positive ion reflector mode of the purified MGPs (deacylated and peracetylated MGLPs)
from M. smegmatis mc
2155 wild-type, mc
2DMSMEG_5084 and mc
2DMSMEG_5084/pVV16MSMEG_5084. MGPx,y denotes a form of MGP
containing6glucosyl units of which y are O-methylated. All annotated peaks correspond to [M-H+2Na]
+ pseudomolecular ions.
doi:10.1371/journal.pone.0005447.g004
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Enzymatically-active whole cell-free extracts from M. smegmatis
were prepared by sonication of M. smegmatis cells for 8 min under
the form of 8660 s-pulses with 90 s-cooling intervals between
pulses followed by centrifugation of the extracts at 15,0006g for
30 min to remove unbroken cells. Assays performed with
mycobacterial cell-free extracts contained 0.5 mM (0.05 mCi)
UDP-D-[U-
14C]Glc (GE Healthcare), 1 to 3 mM D-3-phospho-
glycerate (Sigma), 20 mM MgCl2, 150 to 300 mgo fM. smegmatis
proteins and 25 mM Tris-HCl buffer pH 8.0 in a total volume of
100 ml. Reaction mixtures were incubated at 37uC for 5 to 30 min
and terminated by cooling in ethanol/dry ice. Reaction products
were separated by TLC on aluminum-backed silica gel 60-
precoated plates F254 developed in 1-propanol/ethyl acetate/
water/25% ammonia (50:10:30:10 by vol.) and revealed by
autoradiography. The products of the reactions were character-
ized by co-migration with authentic glucosylglycerate (GG) and
glucosyl-3phosphoglycerate (GPG) standards produced in vitro by
M. smegmatis mc
2155 cell free extracts. GPG was purified by
preparative TLC and structurally characterized using Electro-
Spray Ionisation mass spectrometry (ESI/MS) on a 6220 TOF
(Agilent Technologies) in the negative ion mode (Fig. S2). GG was
produced by treating purified GPG with 4 U alkaline phosphatase
(Sigma) for 30 min at 37uC.
Fatty acid and mycolic acid analysis
Fatty acid and mycolic acid methyl esters were prepared from
whole M. smegmatis cells by methanolysis using methanolic-HCl
(Supelco). Mycolic acid methyl esters were analyzed by TLC using
n-hexane/ethyl acetate (95:5; three developments) as the eluent.
Fatty acid methyl esters were analyzed by gas chromatography-
mass spectrometry (GC-MS) on a Varian CP-3800 gas chromato-
graph equipped with a Varian 320-MS TQ mass spectrometer
using a 5% phenyl-methyl low bleed Factor Four GC column
operating at a temperature of 50uC for 1 min followed by
programmed increases of 30uC per min to 100uC and 10uC per
min to 300uC.
Supporting Information
Figure S1 Comparative analysis of the fatty acid and mycolic
acid compositions of wild-type M. smegmatis mc2155 and
mc2(delta)MSMEG_5084. Wild-type mc2155 and mc2(delta)MS-
MEG_5084 were grown in Sauton’s medium as surface pellicles at
37uC. A) Mycolic acid methyl esters (MAMEs) were analyzed by
TLC using n-hexane/ethyl acetate (95:5; three developments) as
the eluent and revealed by charring with cupric sulfate (10% in a
8% phosphoric acid solution); B) Fatty acid methyl esters (FAMEs)
were analyzed by gas chromatography-mass spectrometry. Shown
are the relative percentages of each fatty acid in the strains.
Found at: doi:10.1371/journal.pone.0005447.s001 (0.03 MB
PDF)
Figure S2 Negative ion ESI/MS of GPG. GPG was purified by
preparative TLC. The spectrum in the m/z range 335–385 atomic
mass units (amu) is shown.
Found at: doi:10.1371/journal.pone.0005447.s002 (0.02 MB
PDF)
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